BLM-IN-2, a Blooms Syndrome Protein (BLM) inhibitor, exhibits an IC50 of 0.8 µM and shows efficacy in suppressing proliferation, invasion, cell cycle arrest, and apoptosis in colorectal cancer (CRC) cells, making it a potential candidate for CRC research
Molecular Weight:
605.58
Formula:
C33H38BrFN4O
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted